4/A: Conduit Pharmaceuticals Insider Sells Shares

Sentiment:

Insider Transaction (Form 4/A)


Andrew Regan and 1 other reported changes in beneficial ownership of Conduit Pharmaceuticals Inc. common stock on July 30, 2026.

Summary

  • Other acquisition/disposition: acquired 543,683 Common Stock on August 28, 2026; holds 569,322 after (Indirect).
  • Open-market sale: disposed of 29 Common Stock on August 28, 2026; holds 569,322 after (Indirect).
  • Other acquisition/disposition: acquired 5,436,830 Pre-Funded Warrants at $0.00 ($544) on July 30, 2026; holds 543,683 after (Indirect).
  • In-the-money derivative exercise: disposed of 543,683 Pre-Funded Warrants at $0.00 ($54) on August 28, 2026 (Indirect).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $0 of stock on the open market.

Insider Transactions

Andrew Regan β€” Director, Officer (Chief Executive Officer), 10% owner

Corvus Capital Ltd. β€” 10% owner

DateTransactionSecuritySharesPriceValueHeld After
2026-08-28Other acquisition/dispositionCommon Stock543,683β€”β€”569,322
2026-08-28Open-market saleCommon Stock29β€”β€”569,322
2026-07-30Other acquisition/dispositionPre-Funded Warrants5,436,830$0$544543,683
2026-08-28In-the-money derivative exercisePre-Funded Warrants543,683$0$540

Key Dates

DateDescription
2026-08-28Other acquisition/disposition (543,683 shares)
2026-08-28Open-market sale (29 shares)
2026-07-30Other acquisition/disposition (5,436,830 shares)
2026-08-28In-the-money derivative exercise (543,683 shares)

Keywords

insider transaction, Form 4/A, CDT, CDT Equity Inc., bearish, Andrew Regan, Corvus Capital Ltd.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.